The diagnosis of Fanconi anemia (FA) is based on the association of congeni
tal malformations, bone marrow failure syndrome, and hypersensitivity to ch
romo somal breaks induced by cross-linking agents. In the absence of typica
l features, the diagnosis is not easy to establish because there is no simp
le and cost-effective test; thus, investigators must rely on specialized an
alyses of chromosomal breaks. Because we observed elevated serum alpha-feto
protein (sAFP) levels in FA patients, we investigated this parameter as a p
ossible diagnostic tool. Serum AFP levels from 61 FA patients and 27 contro
ls with acquired aplastic anemia or other inherited bone marrow failure syn
dromes were analyzed using a fluoroimmunoassay based on the TRACE technolog
y Serum AFP levels were significantly more elevated (P < .0001) in FA than
in non FA aplastic patients. In the detection of FA patients among patients
with bone marrow failure syndromes, this assay had a sensitivity of 93% an
d a specificity of 100%, This elevation was not explained by liver abnormal
ities. Levels of sAFP were unchanged during at least 4 years of follow-up,
and allogeneic bone marrow transplantation did not modify sAFP levels. Thre
e of 4 FA patients with mosaicism as well as 5 of 6 FA patients with myelod
ysplastic syndrome were detected by this test. Heterozygous parents of FA p
atients had normal sAFP levels. Measurement of sAFP levels with this automa
ted, cost effective, and reproducible fluoroimmunoassay could be proposed f
or the preliminary diagnosis of FA whenever this disorder is suspected. (C)
2000 by The American Society of Hematology.